Antidepressant response and fluvoxamine plasma concentrations: a pilot study

被引：0

作者：

F. Schwarzenbach

P. Demoly

D. Bisschop

A.M. Bel

C. Netillard

S. Limat

M.C. Woronoff‐Lemsi

S. Bouquet

S. Vandel

机构：

[1] Psychiatric Hospital,Pharmacy

[2] Psychiatric Hospital,Psychiatry

[3] University Hospital,Pharmacy

[4] University Hospital,Pharmacokinetic

[5] University Hospital,Pharmacology

来源：

Pharmacy World and Science | 2003年 / 25卷

关键词：

Antidepressant; Fluvoxamine; Plasma concentration; Therapeutic drug monitoring;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The objective of this pilot study was to examine the relation between fluvoxamine (FVX) plasma concentrations, therapeutic response and side effects during a four-week treatment period. Twenty‐two patients who met the DSM‐IV criteria for major depression received 100 mg FVX during the first 2 days of treatment and then 150 or 200 mg/day. No clear relationship between plasma concentrations and side effects was detectable. A relationship between plasma concentrations and clinical efficacy was detectable after 21 days but not after 28 days of treatment. These preliminary results indicate that therapeutic drug monitoring might be useful for patients treated with FVX.

引用

页码：27 / 29

页数：2

共 39 条

[1]

Vozeh S.(1987)Cost-effectiveness of therapeutic drug monitoring Clin Pharmacokinet 13 131-40

[2]

Schweitzer C(1986)Fluorimetric determination of fluvoxamine or clovoxamine in human plasma after thin-layer chromatographic or high-performance liquid chromatographic separation J Chromatogr 382 405-11

[3]

Spahn H(1998)Fluvoxamine or placebo in the treatment of panic disorder and relationship to blood concentrations of fluvoxamine Pharmacopsychiatry 31 117-21

[4]

Mutschler E.(1998)Non-linear fluvoxamine disposition Br J Clin Pharmacol 45 257-63

[5]

Sandmann J(1985)A Belgian multicentre study of fluvoxamine in depressive outpatients Acta Psychiatr Belg 85 636-43

[6]

Lörch B(1987)Treatment of major affective disorder with fluvoxamine J Clin Psychiatry 48 65-8

[7]

Bandelow B(1993)Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effects Eur Neuropsychopharmacol 3 13-21

[8]

Härtter S(1982)Fluvoxamine and clomipramine in endogenous depression J Affect Disord 4 249-59

[9]

Winter P(1997)Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design J Clin Psychiatry 58 7-14

[10]

Hiemke C(1992)Plasma levels of fluvoxamine and maprotiline and clinical response in major depression Pharmacopsychiatry 25 106-undefined

← 1 2 3 4 →